These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 19802403)
21. Primary urinary tract infection in infants: prophylaxis for uncomplicated pyelonephritis. Wan KS; Liu CK; Chen LH Nephrology (Carlton); 2007 Apr; 12(2):178-81. PubMed ID: 17371343 [TBL] [Abstract][Full Text] [Related]
22. [Febrile urinary infection: ambulatory treatment of infants: a Quebec study demonstrates this is possible]. Perspect Infirm; 2010; 7(5):30-1. PubMed ID: 21744630 [No Abstract] [Full Text] [Related]
23. [Variables influencing duration of hospitalization for urinary tract infection]. Ramiro Ayán L; Lassaletta Atienza A; González Santiago P; Gómez Carrasco JA; García De Frías E An Esp Pediatr; 2002 Jun; 56(6):500-4. PubMed ID: 12042147 [TBL] [Abstract][Full Text] [Related]
24. The need for a second dose of ceftriaxone in febrile infants age 4-8 weeks. Allen SE; Walsh-Kelly CM; Hennes HH WMJ; 2000 Apr; 99(2):60-2. PubMed ID: 10843028 [TBL] [Abstract][Full Text] [Related]
26. Outpatient management without antibiotics of fever in selected infants. Baker MD; Bell LM; Avner JR N Engl J Med; 1993 Nov; 329(20):1437-41. PubMed ID: 8413453 [TBL] [Abstract][Full Text] [Related]
27. Ambulatory intravenous antibiotic therapy for children with preseptal cellulitis. Brugha RE; Abrahamson E Pediatr Emerg Care; 2012 Mar; 28(3):226-8. PubMed ID: 22344208 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of short-term intravenous antibiotic in neonates with urinary tract infection. Magín EC; García-García JJ; Sert SZ; Giralt AG; Cubells CL Pediatr Emerg Care; 2007 Feb; 23(2):83-6. PubMed ID: 17351406 [TBL] [Abstract][Full Text] [Related]
29. Antibiotic resistance pattern and empirical therapy for urinary tract infections in children. Al-Harthi AA; Al-Fifi SH Saudi Med J; 2008 Jun; 29(6):854-8. PubMed ID: 18521464 [TBL] [Abstract][Full Text] [Related]
30. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573 [TBL] [Abstract][Full Text] [Related]
31. Clinical and demographic factors associated with urinary tract infection in young febrile infants. Zorc JJ; Levine DA; Platt SL; Dayan PS; Macias CG; Krief W; Schor J; Bank D; Shaw KN; Kuppermann N; Pediatrics; 2005 Sep; 116(3):644-8. PubMed ID: 16140703 [TBL] [Abstract][Full Text] [Related]
32. Outpatient treatment of febrile infants 28 to 89 days of age with intramuscular administration of ceftriaxone. Baskin MN; O'Rourke EJ; Fleisher GR J Pediatr; 1992 Jan; 120(1):22-7. PubMed ID: 1731019 [TBL] [Abstract][Full Text] [Related]
33. Ambulatory treatment with ceftriaxone in febrile neutropenic children. Kaplinsky C; Drucker M; Goshen J; Tamary H; Cohen IJ; Zaizov R Isr J Med Sci; 1994 Aug; 30(8):649-51. PubMed ID: 8045751 [TBL] [Abstract][Full Text] [Related]
34. Follow-up urine cultures and fever in children with urinary tract infection. Currie ML; Mitz L; Raasch CS; Greenbaum LA Arch Pediatr Adolesc Med; 2003 Dec; 157(12):1237-40. PubMed ID: 14662582 [TBL] [Abstract][Full Text] [Related]
35. [Short duration of initial intravenous treatment in 70 pediatric patients with osteoarticular infections]. Prado S MA; Lizama C M; Peña D A; Valenzuela M C; Viviani S T Rev Chilena Infectol; 2008 Feb; 25(1):30-6. PubMed ID: 18273522 [TBL] [Abstract][Full Text] [Related]
36. [The diagnosis and therapy of first community acquired urinary tract infection in children]. Miron D; Grossman Z Harefuah; 2009 Nov; 148(11):778-82, 792, 791. PubMed ID: 20027983 [TBL] [Abstract][Full Text] [Related]
37. Meropenem plus amikacin versus piperacillin-tazobactam plus netilmicin as empiric therapy for high-risk febrile neutropenia in children. Aksoylar S; Cetingül N; Kantar M; Karapinar D; Kavakli K; Kansoy S Pediatr Hematol Oncol; 2004 Mar; 21(2):115-23. PubMed ID: 15160510 [TBL] [Abstract][Full Text] [Related]
38. Early hospital discharge followed by outpatient management versus continued hospitalization of children with cancer, fever, and neutropenia at low risk for invasive bacterial infection. Santolaya ME; Alvarez AM; Avilés CL; Becker A; Cofré J; Cumsille MA; O'Ryan ML; Payá E; Salgado C; Silva P; Tordecilla J; Varas M; Villarroel M; Viviani T; Zubieta M J Clin Oncol; 2004 Sep; 22(18):3784-9. PubMed ID: 15365075 [TBL] [Abstract][Full Text] [Related]
39. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion. Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195 [TBL] [Abstract][Full Text] [Related]
40. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients. Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]